Jane T Lombard, MD
Cardiovascular Disease (Cardiology) · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Offices
- 2
Offices
2 locations · El Camino Health Medical Network LLC · Physician Services at El Camino Hospital
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lombard’s office at (408) 871-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence G55024 · Current
Licensed to practise in California · since 1985 · expires 2027-03-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$34,658
Medicare paid this office $34,658 for 523 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 85 | $14,071 | $84 |
| New patient visit (45+ min) | 60 | $6,516 | $109 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $4,124 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 340 | $2,838 | $7 |
| Short return visit (20+ min) | 32 | $1,831 | $54 |
See all 9 services
| Return visit (30+ min) | 85 | $14,071 | $84 |
| New patient visit (45+ min) | 60 | $6,516 | $109 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $4,124 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 340 | $2,838 | $7 |
| Short return visit (20+ min) | 32 | $1,831 | $54 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 38 | $863 | $23 |
| New patient visit (30+ min) | 11 | $745 | $68 |
| Heart muscle strain imaging | 18 | $257 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $149 | $12 |
Who their Medicare patients are
523 Original Medicare patients in 2024. Average age 78 · Under 65 5% · 85 and older 26% · Women 62% · Also on Medicaid 21% · Health risk score 1.77. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 39% · Diabetes 34% · Atrial fibrillation 33% · Chronic kidney disease 32% · Heart failure 29% · Depression 24% · Cancer 23% · Dementia 17% · COPD 15% · Stroke 15%.
The office billed $197,945, Medicare allowed $47,638 and paid $34,658; for 904 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 523 | 904 | 78 | 1.77 | $197,945 | $34,658 |
| 2023 | 500 | 795 | 78 | 1.77 | $143,226 | $24,687 |
| 2022 | 398 | 620 | 78 | 1.67 | $89,834 | $14,630 |
| 2021 | 386 | 512 | 78 | 1.65 | $61,782 | $10,353 |
| 2020 | 271 | 353 | 78 | 1.86 | $25,941 | $3,657 |
| 2019 | 269 | 350 | 80 | 1.80 | $48,423 | $5,980 |
| 2018 | 939 | 1,623 | 77 | 1.43 | $298,557 | $74,041 |
| 2017 | 932 | 1,575 | 77 | 1.42 | $286,113 | $73,442 |
| 2016 | 1,090 | 1,762 | 78 | 1.62 | $321,974 | $81,790 |
| 2015 | 819 | 1,401 | 78 | 1.55 | $283,675 | $72,537 |
| 2014 | 1,027 | 1,874 | 76 | 1.13 | $490,957 | $119,229 |
| 2013 | 1,242 | 2,324 | 77 | 1.31 | $607,144 | $144,065 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 46 | $7,329 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 59 | $4,785 | $59 |
| New patient visit (45+ min) | 43 | $4,752 | $111 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 342 | $3,147 | $7 |
| Short return visit (20+ min) | 26 | $1,703 | $55 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 34 | $795 | $23 |
| New patient visit (30+ min) | 11 | $680 | $62 |
| Heart muscle strain imaging | 21 | $406 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $164 | $11 |
2022: 9 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 41 | $3,400 | $59 |
| Return visit (30+ min) | 18 | $2,808 | $83 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 293 | $2,770 | $7 |
| New patient visit (45+ min) | 18 | $1,946 | $108 |
| Short return visit (20+ min) | 23 | $1,588 | $57 |
| New patient visit (30+ min) | 11 | $839 | $76 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 15 | $345 | $23 |
| Heart muscle strain imaging | 21 | $330 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 27 | $304 | $11 |
2021: 5 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 323 | $2,953 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 29 | $2,358 | $66 |
| Return visit (30+ min) | 17 | $2,133 | $93 |
| New patient visit (45+ min) | 18 | $1,765 | $98 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $230 | $14 |
2020: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 264 | $2,654 | $8 |
2019: 3 services
| Short return visit (20+ min) | 81 | $2,733 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 178 | $1,550 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 11 | $1,315 | $120 |
2018: 10 services
| Short return visit (20+ min) | 240 | $28,717 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 55 | $11,681 | $205 |
| Return visit (30+ min) | 93 | $10,417 | $87 |
| New patient visit (30+ min) | 61 | $5,507 | $90 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 305 | $4,692 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 331 | $3,233 | $7 |
| Programming of dual lead pacemaker system | 29 | $2,299 | $51 |
| New patient visit (45+ min) | 16 | $2,133 | $133 |
| External ekg recording for more than 48 hours up to 21 days | 22 | $625 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 22 | $539 | $25 |
2017: 10 services
| Short return visit (20+ min) | 218 | $24,792 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 58 | $13,073 | $225 |
| Return visit (30+ min) | 102 | $12,727 | $87 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 343 | $5,260 | $15 |
| New patient visit (30+ min) | 53 | $4,462 | $84 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 302 | $2,915 | $8 |
| Programming of dual lead pacemaker system | 30 | $2,630 | $47 |
| New patient visit (45+ min) | 16 | $2,390 | $149 |
| External ekg recording for more than 48 hours up to 21 days | 21 | $508 | $24 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 21 | $451 | $21 |
2016: 7 services
| Short return visit (20+ min) | 210 | $22,024 | $60 |
| Return visit (30+ min) | 136 | $20,904 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 55 | $12,701 | $227 |
| New patient visit (45+ min) | 50 | $7,280 | $146 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 319 | $4,919 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 483 | $3,923 | $7 |
| Programming of dual lead pacemaker system | 42 | $3,638 | $47 |
2015: 7 services
| Short return visit (20+ min) | 215 | $21,518 | $63 |
| Return visit (30+ min) | 111 | $17,303 | $97 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 50 | $12,579 | $237 |
| New patient visit (45+ min) | 31 | $4,706 | $152 |
| Programming of dual lead pacemaker system | 46 | $3,721 | $49 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 246 | $3,327 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 282 | $2,898 | $8 |
2014: 16 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 94 | $21,833 | $223 |
| Short return visit (20+ min) | 236 | $21,476 | $58 |
| Return visit (30+ min) | 125 | $19,249 | $91 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 26 | $12,040 | $463 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 603 | $8,626 | $14 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 26 | $6,855 | $132 |
| Programming of dual lead pacemaker system | 48 | $3,837 | $49 |
| Injection, regadenoson, 0.1 mg | 16 | $2,663 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 35 | $2,251 | $63 |
| New patient visit (30+ min) | 23 | $2,175 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 41 | $2,095 | $51 |
| New patient visit (45+ min) | 14 | $1,529 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,443 | $60 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 17 | $1,076 | $34 |
| Electrocardiogram (ecg) 2-day continuous | 19 | $393 | $21 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 19 | $369 | $19 |
2013: 20 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 125 | $23,338 | $184 |
| Short return visit (20+ min) | 236 | $21,331 | $59 |
| Return visit (30+ min) | 139 | $17,661 | $91 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 32 | $15,753 | $492 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 563 | $9,344 | $16 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 33 | $8,738 | $132 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 71 | $4,597 | $65 |
| Programming of dual lead pacemaker system | 50 | $4,484 | $50 |
| Injection, regadenoson, 0.1 mg | 24 | $3,933 | None |
| New patient visit (30+ min) | 39 | $3,666 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 55 | $2,936 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,307 | $62 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 31 | $1,728 | $34 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 127 | $1,723 | $7 |
| New patient visit (45+ min) | 12 | $1,694 | $141 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,174 | $84 |
| Electrocardiogram (ecg) 2-day continuous | 29 | $833 | $29 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 29 | $678 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 18 | $376 | $21 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 18 | $176 | $10 |
Medicaid work
$1,170 in 2024
Medicaid paid $1,170 for 248 billed services this clinician did in 2024, up to 67 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 248 | $1,170 |
| 2024 | 248 | 1 | 67 | $1,170 |
| 2023 | 252 | 1 | 113 | $1,147 |
| 2022 | 194 | 1 | 80 | $1,032 |
| 2021 | 175 | 1 | 74 | $604 |
| 2020 | 132 | 1 | 71 | $580 |
| 2019 | 95 | 2 | 38 | $1,379 |
| 2018 | 178 | 2 | 71 | $1,047 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 252 | $1,147 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 194 | $1,032 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 175 | $604 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 132 | $580 |
2019
| Short return visit (20+ min) | 20 | $1,111 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 75 | $268 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 164 | $784 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 14 | $263 |
Drugs they prescribed that Part D paid
$34,954
Pharmacies billed $34,954 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 217) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
181 generic and 36 brand-name prescriptions · $34,954 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 19 | $20,199 | $1,063 |
| Xarelto | 14 | $10,846 | $775 |
| Metoprolol | 24 | $388 | $16 |
| Losartan | 17 | $293 | $17 |
| Atorvastatin | 12 | $258 | $22 |
See all 9 drugs
| Eliquis | 19 | $20,199 | $1,063 |
| Xarelto | 14 | $10,846 | $775 |
| Metoprolol | 24 | $388 | $16 |
| Losartan | 17 | $293 | $17 |
| Atorvastatin | 12 | $258 | $22 |
| Rosuvastatin | 23 | $219 | $10 |
| Amlodipine Besylate | 20 | $161 | $8 |
| Metoprolol | 11 | $75 | $7 |
| Carvedilol | 12 | $37 | $3 |
Year by year
| 2024 | 217 | 55 | 0% (0) | 17% | $34,954 |
| 2023 | 255 | 52 | 0% (0) | None | $40,734 |
| 2022 | 93 | 25 | 0% (0) | 14% | $11,461 |
| 2021 | 63 | 18 | 0% (0) | 17% | $7,364 |
| 2020 | 20 | 15 | 0% (0) | None | $463 |
| 2019 | 1,100 | 237 | 0% (0) | 20% | $142,023 |
| 2018 | 2,320 | 290 | 0% (0) | 15% | $205,141 |
| 2017 | 2,279 | 281 | 0% (0) | 13% | $126,509 |
| 2016 | 2,190 | 259 | 0% (0) | 15% | $94,226 |
| 2015 | 2,017 | 234 | None | 17% | $80,851 |
| 2014 | 2,101 | 257 | None | 20% | $99,829 |
| 2013 | 1,950 | 242 | None | 22% | $86,947 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Eliquis | 28 | $26,843 | $959 |
| Amlodipine Besylate | 49 | $542 | $11 |
| Losartan | 23 | $355 | $15 |
| Carvedilol | 15 | $348 | $23 |
| Metoprolol | 20 | $329 | $16 |
| Rosuvastatin | 19 | $224 | $12 |
2022: 2 drugs
| Carvedilol | 13 | $185 | $14 |
| Amlodipine Besylate | 19 | $152 | $8 |
2019: 23 drugs
| Eliquis | 153 | $105,277 | $688 |
| Xarelto | 19 | $13,324 | $701 |
| Metoprolol | 108 | $3,102 | $29 |
| Flecainide Acetate | 45 | $2,506 | $56 |
| Labetalol | 25 | $1,571 | $63 |
| Atorvastatin | 89 | $1,430 | $16 |
| Rosuvastatin | 31 | $1,157 | $37 |
| Diltiazem 24hr Er (Cd) | 16 | $875 | $55 |
| Ezetimibe | 26 | $781 | $30 |
| Losartan | 36 | $618 | $17 |
| Isosorbide Mononitrate Er | 28 | $590 | $21 |
| Carvedilol | 49 | $555 | $11 |
| Simvastatin | 50 | $497 | $10 |
| Digoxin | 16 | $389 | $24 |
| Amlodipine Besylate | 55 | $378 | $7 |
| Lisinopril | 57 | $373 | $7 |
| Potassium Chloride | 11 | $283 | $26 |
| Clopidogrel | 12 | $243 | $20 |
| Furosemide | 37 | $217 | $6 |
| Atenolol | 23 | $178 | $8 |
| Triamterene-Hydrochlorothiazid | 11 | $154 | $14 |
| Hydrochlorothiazide | 31 | $149 | $5 |
| Hydralazine | 15 | $81 | $5 |
2018: 36 drugs
| Eliquis | 212 | $129,040 | $609 |
| Xarelto | 17 | $13,563 | $798 |
| Metoprolol | 276 | $7,618 | $28 |
| Flecainide Acetate | 99 | $6,413 | $65 |
| Atorvastatin | 194 | $3,463 | $18 |
| Propafenone | 16 | $2,911 | $182 |
| Ezetimibe | 29 | $2,804 | $97 |
| Labetalol | 34 | $2,063 | $61 |
| Digoxin | 39 | $2,004 | $51 |
| Digox | 22 | $1,545 | $70 |
| Cartia Xt | 42 | $1,477 | $35 |
| Rosuvastatin | 30 | $1,438 | $48 |
| Diltiazem 24hr Er (Cd) | 30 | $1,337 | $45 |
| Carvedilol | 114 | $1,274 | $11 |
| Isosorbide Mononitrate Er | 49 | $1,047 | $21 |
| Amiodarone | 45 | $897 | $20 |
| Lisinopril | 129 | $894 | $7 |
| Amlodipine Besylate | 133 | $861 | $6 |
| Simvastatin | 91 | $815 | $9 |
| Losartan | 68 | $802 | $12 |
| Nitroglycerin | 31 | $755 | $24 |
| Warfarin | 28 | $611 | $22 |
| Valsartan | 12 | $601 | $50 |
| Potassium Chloride | 24 | $573 | $24 |
| Furosemide | 99 | $473 | $5 |
| Clopidogrel | 27 | $414 | $15 |
| Megestrol Acetate | 20 | $400 | $20 |
| Atenolol | 54 | $383 | $7 |
| Torsemide | 21 | $288 | $14 |
| Metoprolol | 41 | $273 | $7 |
| Hydrochlorothiazide | 36 | $265 | $7 |
| Triamterene-Hydrochlorothiazid | 20 | $252 | $13 |
| Spironolactone | 40 | $250 | $6 |
| Benazepril | 23 | $181 | $8 |
| Clonidine | 14 | $120 | $9 |
| Hydralazine | 16 | $82 | $5 |
2017: 34 drugs
| Eliquis | 106 | $53,240 | $502 |
| Metoprolol | 203 | $6,411 | $32 |
| Flecainide Acetate | 99 | $6,151 | $62 |
| Ezetimibe | 26 | $5,735 | $221 |
| Propafenone Hcl Er | 13 | $4,206 | $324 |
| Atorvastatin | 188 | $3,472 | $18 |
| Digox | 25 | $2,900 | $116 |
| Cartia Xt | 65 | $1,635 | $25 |
| Diltiazem 24hr Er | 56 | $1,624 | $29 |
| Isosorbide Mononitrate Er | 70 | $1,587 | $23 |
| Carvedilol | 119 | $1,116 | $9 |
| Warfarin | 65 | $1,109 | $17 |
| Potassium Chloride | 28 | $1,080 | $39 |
| Simvastatin | 105 | $1,069 | $10 |
| Amlodipine Besylate | 134 | $992 | $7 |
| Labetalol | 22 | $965 | $44 |
| Rosuvastatin | 16 | $954 | $60 |
| Digoxin | 18 | $941 | $52 |
| Lisinopril | 157 | $840 | $5 |
| Valsartan | 20 | $828 | $41 |
| Nitroglycerin | 37 | $697 | $19 |
| Clopidogrel | 44 | $634 | $14 |
| Pravastatin | 16 | $573 | $36 |
| Amiodarone | 38 | $548 | $14 |
| Losartan | 48 | $534 | $11 |
| Furosemide | 89 | $444 | $5 |
| Torsemide | 23 | $435 | $19 |
| Spironolactone | 42 | $398 | $9 |
| Atenolol | 50 | $326 | $7 |
| Megestrol Acetate | 13 | $299 | $23 |
| Triamterene-Hydrochlorothiazid | 20 | $272 | $14 |
| Hydrochlorothiazide | 49 | $253 | $5 |
| Metoprolol | 52 | $253 | $5 |
| Benazepril | 24 | $240 | $10 |
2016: 37 drugs
| Eliquis | 34 | $17,069 | $502 |
| Zetia | 38 | $12,724 | $335 |
| Crestor | 23 | $7,669 | $333 |
| Propafenone Hcl Er | 13 | $6,221 | $479 |
| Metoprolol | 169 | $4,732 | $28 |
| Flecainide Acetate | 95 | $4,121 | $43 |
| Atorvastatin | 209 | $3,442 | $16 |
| Diltiazem 24hr Er | 58 | $1,913 | $33 |
| Digox | 19 | $1,350 | $71 |
| Simvastatin | 114 | $1,174 | $10 |
| Amlodipine Besylate | 142 | $1,171 | $8 |
| Carvedilol | 131 | $1,166 | $9 |
| Diltiazem 24hr Cd | 15 | $1,113 | $74 |
| Warfarin | 87 | $1,091 | $13 |
| Isosorbide Mononitrate Er | 60 | $1,071 | $18 |
| Lisinopril | 168 | $991 | $6 |
| Dilt-Xr | 11 | $876 | $80 |
| Sotalol Af | 11 | $787 | $72 |
| Digoxin | 15 | $749 | $50 |
| Furosemide | 116 | $744 | $6 |
| Labetalol | 17 | $730 | $43 |
| Amiodarone | 31 | $730 | $24 |
| Potassium Chloride | 26 | $696 | $27 |
| Nitrostat | 22 | $641 | $29 |
| Valsartan | 13 | $565 | $43 |
| Losartan | 55 | $533 | $10 |
| Clopidogrel | 39 | $497 | $13 |
| Spironolactone | 47 | $495 | $11 |
| Propafenone | 12 | $485 | $40 |
| Lovastatin | 17 | $462 | $27 |
| Atenolol | 45 | $428 | $10 |
| Metoprolol | 50 | $347 | $7 |
| Cartia Xt | 17 | $328 | $19 |
| Triamterene-Hydrochlorothiazid | 28 | $286 | $10 |
| Hydrochlorothiazide | 37 | $259 | $7 |
| Torsemide | 16 | $231 | $14 |
| Benazepril | 20 | $193 | $10 |
2015: 36 drugs
| Crestor | 37 | $9,017 | $244 |
| Propafenone Hcl Er | 15 | $8,874 | $592 |
| Xarelto | 15 | $7,256 | $484 |
| Zetia | 17 | $5,749 | $338 |
| Metoprolol | 154 | $5,061 | $33 |
| Eliquis | 13 | $4,888 | $376 |
| Flecainide Acetate | 87 | $4,305 | $49 |
| Atorvastatin | 199 | $3,823 | $19 |
| Digox | 34 | $1,494 | $44 |
| Warfarin | 78 | $1,309 | $17 |
| Valsartan | 15 | $1,307 | $87 |
| Simvastatin | 115 | $1,195 | $10 |
| Diltiazem 24hr Er | 39 | $1,044 | $27 |
| Labetalol | 20 | $970 | $49 |
| Carvedilol | 116 | $897 | $8 |
| Lisinopril | 175 | $880 | $5 |
| Isosorbide Mononitrate Er | 62 | $828 | $13 |
| Propafenone | 15 | $698 | $47 |
| Nitrostat | 33 | $620 | $19 |
| Cartia Xt | 12 | $584 | $49 |
| Losartan | 62 | $577 | $9 |
| Digoxin | 13 | $563 | $43 |
| Amlodipine Besylate | 100 | $525 | $5 |
| Furosemide | 82 | $517 | $6 |
| Potassium Chloride | 20 | $516 | $26 |
| Clopidogrel | 50 | $511 | $10 |
| Benazepril | 14 | $438 | $31 |
| Atenolol | 43 | $363 | $8 |
| Metoprolol | 47 | $341 | $7 |
| Spironolactone | 47 | $305 | $6 |
| Amiodarone | 17 | $279 | $16 |
| Lovastatin | 18 | $264 | $15 |
| Hydrochlorothiazide | 31 | $199 | $6 |
| Triamterene-Hydrochlorothiazid | 17 | $199 | $12 |
| Torsemide | 11 | $156 | $14 |
| Sertraline | 12 | $60 | $5 |
2014: 38 drugs
| Xarelto | 34 | $10,578 | $311 |
| Crestor | 42 | $10,069 | $240 |
| Metoprolol | 182 | $7,056 | $39 |
| Zetia | 24 | $5,801 | $242 |
| Eliquis | 17 | $5,080 | $299 |
| Diovan | 15 | $4,438 | $296 |
| Atorvastatin | 165 | $4,055 | $25 |
| Flecainide Acetate | 90 | $3,903 | $43 |
| Fenofibrate | 18 | $3,262 | $181 |
| Digox | 39 | $1,974 | $51 |
| Fenofibrate | 25 | $1,785 | $71 |
| Clopidogrel | 80 | $1,563 | $20 |
| Labetalol | 35 | $1,558 | $45 |
| Warfarin | 97 | $1,449 | $15 |
| Carvedilol | 118 | $1,432 | $12 |
| Simvastatin | 107 | $1,300 | $12 |
| Diltiazem 24hr Er | 53 | $1,278 | $24 |
| Lisinopril | 158 | $998 | $6 |
| Isosorbide Mononitrate Er | 54 | $802 | $15 |
| Pravastatin | 11 | $707 | $64 |
| Losartan | 45 | $641 | $14 |
| Nitrostat | 43 | $638 | $15 |
| Amlodipine Besylate | 68 | $618 | $9 |
| Propafenone | 11 | $525 | $48 |
| Potassium Chloride | 15 | $525 | $35 |
| Digoxin | 12 | $474 | $40 |
| Metoprolol | 43 | $438 | $10 |
| Losartan-Hydrochlorothiazide | 22 | $382 | $17 |
| Spironolactone | 37 | $362 | $10 |
| Furosemide | 58 | $341 | $6 |
| Triamterene-Hydrochlorothiazid | 19 | $294 | $15 |
| Amiodarone | 25 | $279 | $11 |
| Atenolol | 41 | $275 | $7 |
| Benazepril | 13 | $249 | $19 |
| Lovastatin | 12 | $246 | $21 |
| Hydrochlorothiazide | 38 | $192 | $5 |
| Sertraline | 13 | $92 | $7 |
| Clonidine | 12 | $56 | $5 |
2013: 40 drugs
| Diovan | 26 | $8,278 | $318 |
| Metoprolol | 185 | $6,356 | $34 |
| Atorvastatin | 160 | $6,234 | $39 |
| Fenofibrate | 33 | $5,779 | $175 |
| Crestor | 32 | $5,385 | $168 |
| Zetia | 22 | $4,868 | $221 |
| Flecainide Acetate | 89 | $3,937 | $44 |
| Pradaxa | 12 | $3,179 | $265 |
| Diltiazem 24hr Er | 59 | $3,133 | $53 |
| Clopidogrel | 57 | $2,343 | $41 |
| Simvastatin | 137 | $1,851 | $14 |
| Labetalol | 44 | $1,831 | $42 |
| Carvedilol | 108 | $1,531 | $14 |
| Warfarin | 52 | $1,069 | $21 |
| Isosorbide Mononitrate Er | 53 | $917 | $17 |
| Amlodipine Besylate | 81 | $891 | $11 |
| Lisinopril | 104 | $743 | $7 |
| Sotalol Af | 12 | $659 | $55 |
| Sotalol | 20 | $645 | $32 |
| Nitrostat | 41 | $572 | $14 |
| Atenolol | 45 | $510 | $11 |
| Diltiazem Er | 12 | $481 | $40 |
| Losartan-Hydrochlorothiazide | 18 | $468 | $26 |
| Metoprolol | 43 | $431 | $10 |
| Losartan | 21 | $426 | $20 |
| Furosemide | 68 | $417 | $6 |
| Diltiazem 24hr Cd | 15 | $396 | $26 |
| Triamterene-Hctz | 20 | $359 | $18 |
| Amiodarone | 22 | $353 | $16 |
| Spironolactone | 40 | $351 | $9 |
| Potassium Chloride | 11 | $318 | $29 |
| Bumetanide | 12 | $284 | $24 |
| Lovastatin | 14 | $283 | $20 |
| Hydrochlorothiazide | 33 | $248 | $8 |
| Digox | 18 | $217 | $12 |
| Benazepril | 11 | $158 | $14 |
| Sertraline | 18 | $139 | $8 |
| Oxybutynin Chloride | 12 | $138 | $12 |
| Indapamide | 14 | $93 | $7 |
| Lorazepam | 13 | $64 | $5 |
Money from drug and device companies
$290 in 2025
| 2025 | 3 | 5 | None | $290 |
| 2023 | 1 | 1 | None | $25 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Heartflow | Ffrct | $198 | 2 payments
|
| Medtronic | Corevalve Evolut R | $69 | 2 payments
|
| Esperion Therapeutics | Nexletol | $23 | 1 payment
|
See all 5 published payments
| Esperion Therapeutics | Meals · 2025-12-04 | Nexletol | $23 |
| Medtronic | Meals · 2025-10-19 | Corevalve Evolut R | $26 |
| Medtronic | Meals · 2025-09-04 | Corevalve Evolut R | $43 |
| Heartflow | Meals · 2025-03-19 | Ffrct | $167 |
| Heartflow | Meals · 2025-02-18 | Ffrct | $31 |
See earlier years (2023)
2023: $25
| Novo Nordisk | Wegovy | $25 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1558311050
- Licence
- CA G55024California G55024: Current · expires 2027-03-31
- Trained
- Stanford University School of Medicine, 1983
- Group
- El Camino Health Medical Network LLC · Physician Services at El Camino Hospital
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 2490 Hospital Dr Ste 311, Mountain View, CA, 94040
- NPI first listed
- 2006-05-12
- NPI last updated
- 2025-12-29
- NPI record certified
- 2025-12-29
This is when the NPI record was last certified, not a medical board exam.